OppenheimerFunds’s MEDASSETS INC COM STK (DE) MDAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-769,702
Closed -$23.8M 1792
2015
Q4
$23.8M Sell
769,702
-157,641
-17% -$4.38M 0.03% 516
2015
Q3
$18.6M Buy
927,343
+32,923
+4% +$702K 0.03% 561
2015
Q2
$19.7M Buy
894,420
+183,070
+26% +$3.82M 0.02% 585
2015
Q1
$13.4M Sell
711,350
-48,370
-6% -$920K 0.01% 693
2014
Q4
$15M Buy
759,720
+87,180
+13% +$1.77M 0.02% 659
2014
Q3
$13.9M Buy
672,540
+38,430
+6% +$859K 0.02% 667
2014
Q2
$14.5M Buy
634,110
+206,400
+48% +$4.83M 0.02% 673
2014
Q1
$10.6M Buy
+427,710
New +$9.63M 0.01% 744

OppenheimerFunds's MDAS Position: Q1 2016 in Review

OppenheimerFunds sold out of MEDASSETS INC COM STK (DE) (MDAS) in Q1 2016, closing a stake of 769,702 shares — an estimated $23.8M sold.

OppenheimerFunds first reported a position in MDAS in Q1 2014 and held it in 8 quarters. The position peaked at $23.8M in Q4 2015. 0 funds tracked by Wall St. Rank hold MDAS as of Q1 2016.

  • OppenheimerFunds reported no remaining MEDASSETS INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • OppenheimerFunds sold 769,702 MEDASSETS INC COM STK (DE) shares in Q1 2016, an estimated $23.8M.
  • OppenheimerFunds first reported a position in MEDASSETS INC COM STK (DE) in Q1 2014 and held it in 8 quarters.
  • OppenheimerFunds's MEDASSETS INC COM STK (DE) position peaked at $23.8M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held MEDASSETS INC COM STK (DE) as of Q1 2016.

Based on OppenheimerFunds's 13F filing for Q1 2016, filed 12 May 2016.